Recro Pharma, Inc.
Nanoparticulate meloxicam formulations
Last updated:
Abstract:
The present invention is directed to nanoparticulate compositions comprising meloxicam particles having an effective average particle size of less than about 2000 nm.
Status:
Grant
Type:
Utility
Filling date:
11 Apr 2018
Issue date:
5 Nov 2019